🇺🇸 FDA
Patent

US 10512609

Formulations of (R)-2-amino-3-phenylpropyl carbamate

granted A61KA61K31/165A61K31/27

Quick answer

US patent 10512609 (Formulations of (R)-2-amino-3-phenylpropyl carbamate) held by Jazz Pharmaceuticals Ireland Limited expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Jazz Pharmaceuticals Ireland Limited
Grant date
Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/165, A61K31/27, A61K9/2013, A61K9/2018